The gut microbiota and host health: a new clinical frontier
Tóm tắt
Từ khóa
Tài liệu tham khảo
Muegge, 2011, Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans, Science, 332, 970, 10.1126/science.1198719
Segata, 2012, Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples, Genome Biol, 13, R42, 10.1186/gb-2012-13-6-r42
Zoetendal, 2012, The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates, ISME J, 6, 1415, 10.1038/ismej.2011.212
Lepage, 2013, A metagenomic insight into our gut's microbiome, Gut, 62, 146, 10.1136/gutjnl-2011-301805
Sokol, 2009, Low counts of Faecalibacterium prausnitzii in colitis microbiota, Inflamm Bowel Dis, 15, 1183, 10.1002/ibd.20903
Gerasimidis, 2014, Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition, Inflamm Bowel Dis, 20, 861, 10.1097/MIB.0000000000000023
Bonnet, 2014, Colonization of the human gut by E. coli and colorectal cancer risk, Clin Cancer Res, 20, 859, 10.1158/1078-0432.CCR-13-1343
Thorkildsen, 2013, Dominant fecal microbiota in newly diagnosed untreated inflammatory bowel disease patients, Gastroenterol Res Pract, 2013, 636785, 10.1155/2013/636785
Rajilic-Stojanovic, 2014, The first 1000 cultured species of the human gastrointestinal microbiota, FEMS Microbiol Rev, 38, 996, 10.1111/1574-6976.12075
Louis, 2010, Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene, Environ Microbiol, 12, 304, 10.1111/j.1462-2920.2009.02066.x
Flint, 2012, The role of the gut microbiota in nutrition and health, Nature Rev Gastroenterol Hepatol, 9, 577, 10.1038/nrgastro.2012.156
Ze, 2013, Some are more equal than others: the role of “keystone” species in the degradation of recalcitrant substrates, Gut Microbes, 4, 236, 10.4161/gmic.23998
Macfarlane, 2011, Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics, J Clin Gastroenterol, 45, S120, 10.1097/MCG.0b013e31822fecfe
Arpaia, 2013, Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation, Nature, 504, 451, 10.1038/nature12726
Windey, 2012, Relevance of protein fermentation to gut health, Mol Nutr Food Res, 56, 184, 10.1002/mnfr.201100542
Tang, 2013, Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk, New Engl J Med, 368, 1575, 10.1056/NEJMoa1109400
Clarke, 2014, Minireview: gut microbiota: the neglected endocrine organ, Molec Endocrinol, 28, 1221, 10.1210/me.2014-1108
Tuohy, 2014, Diet-microbe interactions in the gut. Effects on human health and disease
Jones, 2012, Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial, Eur J Clin Nutr, 66, 1234, 10.1038/ejcn.2012.126
Li, 2013, Stable isotope- and mass spectrometry-based metabolomics as tools in drug metabolism: a study expanding tempol pharmacology, J Proteome Res, 12, 1369, 10.1021/pr301023x
Clifford, 2004, Diet-derived phenols in plasma and tissues and their implications for health, Planta Medica, 70, 1103, 10.1055/s-2004-835835
Queipo-Ortuno, 2012, Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers, Am J Clin Nutr, 95, 1323, 10.3945/ajcn.111.027847
Ley, 2005, Obesity alters gut microbial ecology, Proc Natl Acad Sci USA, 102, 11070, 10.1073/pnas.0504978102
Ley, 2006, Microbial ecology: human gut microbes associated with obesity, Nature, 444, 1022, 10.1038/4441022a
Duncan, 2008, Human colonic microbiota associated with diet, obesity and weight loss, Int J Obes, 32, 1720, 10.1038/ijo.2008.155
Claesson, 2012, Gut microbiota composition correlates with diet and health in the elderly, Nature, 488, 178, 10.1038/nature11319
Romero-Corral, 2008, Accuracy of body mass index in diagnosing obesity in the adult general population, Int J Obesity, 32, 959, 10.1038/ijo.2008.11
Zupancic, 2012, Analysis of the gut microbiota in the old order Amish and its relation to the metabolic syndrome, PLoS ONE, 7, e43052, 10.1371/journal.pone.0043052
Bluher, 2010, The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals, Curr Opin Lipidol, 21, 38, 10.1097/MOL.0b013e3283346ccc
Qin, 2012, A metagenome-wide association study of gut microbiota in type 2 diabetes, Nature, 490, 55, 10.1038/nature11450
Karlsson, 2013, Gut metagenome in European women with normal, impaired and diabetic glucose control, Nature, 498, 99, 10.1038/nature12198
Le Chatelier, 2013, Richness of human gut microbiome correlates with metabolic markers, Nature, 500, 541, 10.1038/nature12506
Vrieze, 2012, Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome, Gastroenterol, 143, 913, 10.1053/j.gastro.2012.06.031
Cotillard, 2013, Dietary intervention impact on gut microbial gene richness, Nature, 500, 585, 10.1038/nature12480
Hermes, 2015, Molecular ecological tools to decipher the role of our microbial mass in obesity, Benef Microbes, 6, 61, 10.3920/BM2014.0016
Adams, 2008, Immunology of the gut and liver: a love/hate relationship, Gut, 57, 838, 10.1136/gut.2007.122168
Son, 2010, Contribution of gut bacteria to liver pathobiology, Gastroenterol Res Pract, 2010, 10.1155/2010/453563
de Aguiar Vallim, 2013, Pleiotropic roles of bile acids in metabolism, Cell Metab, 17, 657, 10.1016/j.cmet.2013.03.013
Miele, 2009, Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease, Hepatol, 49, 1877, 10.1002/hep.22848
Drenick, 1982, Hepatic steatosis after intestinal bypass–prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition, Gastroenterol, 82, 535, 10.1016/S0016-5085(82)80403-4
Henao-Mejia, 2012, Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity, Nature, 482, 179, 10.1038/nature10809
Raman, 2013, Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease, Clin Gastroenterol Hepatol, 11, 868, 10.1016/j.cgh.2013.02.015
Zhu, 2013, Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH, Hepatol, 57, 601, 10.1002/hep.26093
Nanji, 1993, Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2, Am J Pathol, 142, 367
Pande, 2009, Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease, Aliment Pharmacol Ther, 29, 1273, 10.1111/j.1365-2036.2009.03994.x
Yan, 2011, Enteric dysbiosis associated with a mouse model of alcoholic liver disease, Hepatol, 53, 96, 10.1002/hep.24018
Yan, 2012, Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease, World J Hepatol, 4, 110, 10.4254/wjh.v4.i4.110
Quraishi, 2014, Probing the microbiota in PSC: the gut adherent microbiota of PSC-IBD is distinct to that of IBD and controls, Hepatol, 60, 267A
Rossen, 2015, The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II, J Crohn's Colitis, 9, 342, 10.1093/ecco-jcc/jju023
Tabibian, 2013, Role of the microbiota and antibiotics in primary sclerosing cholangitis, BioMed Res Int, 2013, 389537, 10.1155/2013/389537
Davies, 2008, Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic, J Pediatr Gastroenterol Nutr, 47, 61, 10.1097/MPG.0b013e31816fee95
Bjornsson, 2005, Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis, Scand J Gastroenterol, 40, 1090, 10.1080/00365520510023288
Kono, 1988, Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits, Gastroenterol, 94, 787, 10.1016/0016-5085(88)90255-7
Mattner, 2008, Liver autoimmunity triggered by microbial activation of natural killer T cells, Cell Host Microbe, 3, 304, 10.1016/j.chom.2008.03.009
Ma, 2013, Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis, World J Gastroenterol, 19, 6911, 10.3748/wjg.v19.i40.6911
Rincon, 2014, Oral probiotic VSL#3 attenuates the circulatory disturbances of patients with cirrhosis and ascites, Liver Int, 34, 1504, 10.1111/liv.12539
Le Roy, 2013, Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice, Gut, 62, 1787, 10.1136/gutjnl-2012-303816
Hold, 2014, Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?, World J Gastroenterol, 20, 1192, 10.3748/wjg.v20.i5.1192
Peterson, 2008, Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases, Cell Host Microbe, 3, 417, 10.1016/j.chom.2008.05.001
Walker, 2011, High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease, BMC Microbiol, 11, 7, 10.1186/1471-2180-11-7
Frank, 2007, Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases, Proc Natl Acad Sci USA, 104, 13780, 10.1073/pnas.0706625104
Swidsinski, 2005, Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease, J Clin Microbiol, 43, 3380, 10.1128/JCM.43.7.3380-3389.2005
Hansen, 2012, Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis, Am J Gastroenterol, 107, 1913, 10.1038/ajg.2012.335
Manichanh, 2006, Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach, Gut, 55, 205, 10.1136/gut.2005.073817
Mukhopadhya, 2011, Detection of Campylobacter concisus and other Campylobacter species in colonic biopsies from adults with ulcerative colitis, PLoS ONE, 6, e21490, 10.1371/journal.pone.0021490
Lupp, 2007, Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae, Cell Host Microbe, 2, 204, 10.1016/j.chom.2007.08.002
Barnich, 2013, E. coli-mediated gut inflammation in genetically predisposed Crohn's disease patients, Pathol Biol (Paris), e65
Erickson, 2012, Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease, PLoS ONE, 7, e49138, 10.1371/journal.pone.0049138
Morgan, 2012, Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment, Genome Biol, 13, R79, 10.1186/gb-2012-13-9-r79
Norman, 2015, Disease-specific alterations in the enteric virome in inflammatory bowel disease, Cell, 160, 447, 10.1016/j.cell.2015.01.002
Kruis, 2004, Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine, Gut, 53, 1617, 10.1136/gut.2003.037747
Dignass, 2012, Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management, J Crohn's Colitis, 6, 991, 10.1016/j.crohns.2012.09.002
Tursi, 2010, Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study, Am J Gastroenterol, 105, 2218, 10.1038/ajg.2010.218
Colman, 2014, Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis, J Crohns Colitis, 8, 1569, 10.1016/j.crohns.2014.08.006
Rossen, 2015, Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis, Gastroenterology, 149, 110, 10.1053/j.gastro.2015.03.045
Moayyedi, 2015, Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized, controlled trial, Gastroenterology, 149, 102, 10.1053/j.gastro.2015.04.001
Rutgeerts, 1995, Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection, Gastroenterol, 108, 1617, 10.1016/0016-5085(95)90121-3
Lindsay, 2006, Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease, Gut, 55, 348, 10.1136/gut.2005.074971
Benjamin, 2011, Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease, Gut, 60, 923, 10.1136/gut.2010.232025
Gionchetti, 2003, Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial, Gastroenterol, 124, 1202, 10.1016/S0016-5085(03)00171-9
Shen, 2014, Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials, Inflamm Bowel Dis, 20, 21, 10.1097/01.MIB.0000437495.30052.be
Arthur, 2012, Intestinal inflammation targets cancer-inducing activity of the microbiota, Science, 338, 120, 10.1126/science.1224820
Wu, 2009, A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17T cell responses, Nat Med, 15, 1016, 10.1038/nm.2015
Ou, 2013, Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans, Am J Clin Nutr, 98, 111, 10.3945/ajcn.112.056689
Scanlan, 2008, Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis, Environ Microbiol, 10, 789, 10.1111/j.1462-2920.2007.01503.x
Marchesi, 2011, Towards the human colorectal cancer microbiome, PLoS ONE, 6, e20447, 10.1371/journal.pone.0020447
Hajishengallis, 2012, The keystone-pathogen hypothesis, Nature Rev Microbiol, 10, 717, 10.1038/nrmicro2873
Sears, 2011, Perspective: alpha-bugs, their microbial partners, and the link to colon cancer, J Infect Dis, 203, 306, 10.1093/jinfdis/jiq061
Tjalsma, 2012, A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects, Nature Rev Microbiol, 10, 575, 10.1038/nrmicro2819
Warren, 2013, Co-occurrence of anaerobic bacteria in colorectal carcinomas, Microbiome, 1, 16, 10.1186/2049-2618-1-16
Shen, 2010, Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas, Gut Microbes, 1, 138, 10.4161/gmic.1.3.12360
Pagnini, 2011, Alteration of local microflora and alpha-defensins hyper-production in colonic adenoma mucosa, J Clin Gastroenterol, 45, 602, 10.1097/MCG.0b013e31820abf29
Boleij, 2013, The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease, Lancet Infect Dis, 13, 719, 10.1016/S1473-3099(13)70107-5
Wang, 2015, Commensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effect, Gut, 64, 459, 10.1136/gutjnl-2014-307213
Prorok-Hamon, 2014, Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer, Gut, 63, 761, 10.1136/gutjnl-2013-304739
Han, 2000, Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells, Infect Immun, 68, 3140, 10.1128/IAI.68.6.3140-3146.2000
Rubinstein, 2013, Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin, Cell Host Microbe, 195
Lu, 2014, Enteric bacterial protein AvrA promotes colonic tumorigenesis and activates colonic beta-catenin signaling pathway, Oncogenesis, 3, e105, 10.1038/oncsis.2014.20
Wu, 2013, Dysbiosis signature of fecal microbiota in colorectal cancer patients, Microb Ecol, 66, 462, 10.1007/s00248-013-0245-9
Zhu, 2014, Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer, PLoS ONE, 9, e90849, 10.1371/journal.pone.0090849
Carbonero, 2012, Microbial pathways in colonic sulfur metabolism and links with health and disease, Front Physiol, 3, 448, 10.3389/fphys.2012.00448
Kashyap, 2013, Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiota, Proc Natl Acad Sci USA, 110, 17059, 10.1073/pnas.1306070110
Wu, 2011, Linking long-term dietary patterns with gut microbial enterotypes, Science, 334, 105, 10.1126/science.1208344
David, 2014, Diet rapidly and reproducibly alters the human gut microbiome, Nature, 505, 559, 10.1038/nature12820
O'Keefe, 2015, Fat, fibre and cancer risk in African Americans and rural Africans, Nature Commun, 6, 6342, 10.1038/ncomms7342
World Health Organization, Food and Agricultural Organization of the United Nations. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. FAO Nutrition Paper, 2001;85.
Hill, 2014, Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic, Nat Rev Gastroenterol Hepatol, 11, 506, 10.1038/nrgastro.2014.66
Ng, 2009, Mechanisms of action of probiotics: recent advances, Inflamm Bowel Dis, 15, 300, 10.1002/ibd.20602
Gibson, 1995, Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics, J Nutr, 125, 1401, 10.1093/jn/125.6.1401
NICE (National Institute for Health and Care Excellence). Faecal microbiota transplant for recurrent Clostridium difficile infection. NICE Interventional Procedure Guidance 2014:485.